USPTO 2015–2025 USPTO PatentsView Foreign Corporation

CathVision ApS

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Cathvision ranks #45,504 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#45,504
of 49,997 US assignees by volume
Top 49%
by Innovation Score (35.6/100)
19.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R45504 · Foreign Corporation #45,504 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,504/49,997
  • PHOTO-FINISH Catalent Ontario
  • CPC-NARROW A61B · 5 areas
  • INNOV-THIN 35.6/100
  • CLAIMS-RICH 19.2 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2023 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Catalent Ontario Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cathvision’s 35.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Cathvision

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cathvision's Innovation Score is 35.6/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Cathvision?

Each dot is one of Cathvision’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cathvision’s own 19.2 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cathvision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 4.95.05.055.05.05.1 1214161820 Granted patents (volume) Avg claims / patent Catalent Ontario Limited - 5, 13.2Catalent OntarioCatapult Products, LLC - 5, 16.6Catapult ProductsCatastrophic Creations LLC - 5, 18.4Catastrophic Crea…Catexel Limited - 5, 17.2CatexelCatholic Kwandong University Industry Foundation - 5, 15.6Catholic Kwandong…Cathx Research Ltd - 5, 17.8Cathx ResearchCaveon, LLC - 5, 18.8CaveonCavion, Inc. - 5, 19.4CavionCathVision ApS - 5, 19.2Cathvision Aps
Cathvision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cathvision's grants concentrate

CathVision ApS is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2020. By volume, Cathvision sits between Catalent Ontario Limited and Cavion, Inc..

Cathvision's three-year grant acceleration

CathVision ApS shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at CathVision's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows CathVision holds 5 patents at rank #45,765, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near CathVision

By rank, the assignees closest to #45,765 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in CathVision's primary technology class.

Cathvision's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2020202120222023 1
USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
CathVision ApS patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 1 20.0%
2021 1 20.0%
2022 2 40.0%
2023 1 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

CathVision ApS's patent record in context - here's where to go next.

  • CathVision ApS's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #45,504 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare CathVision ApS against Catalent Ontario Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.